From the Journals

Study supports multigene panel testing for all breast cancer patients with second primary cancers


 

FROM JCO PRECISION ONCOLOGY

Cancer prevention and screening

The results of this study could lead to better implementation of cancer prevention and screening strategies, according to the researchers.

“As we look at guidelines in development and NCCN recommendations, our data suggest that age should not be part of the criteria for genetic testing in patients who have more than one primary cancer. These patients are at high risk and should be recommended for screening,” Dr. Nathanson said.

“If you see a patient with multiple primary cancers, refer for genetic testing. Age does not matter,” she reiterated.

Future research will look at potentially missing mutations.

“With targeted sequencing, structurally rearranged genes might be missed for those at risk. We will try to identify cancer susceptibility genes and define the true risk of penetrance of these genes in the general population,” Dr. Nathanson said.

This research was supported by grants from government agencies and foundations as well as the University of Pennsylvania. Dr. Nathanson disclosed no conflicts of interest. Other authors disclosed relationships with a range of companies, all listed in the paper.

SOURCE: Maxwell KN et al. JCO Precis Oncol. 2020. doi: 10.1200/PO.19.00301.

Pages

Recommended Reading

Postmenopausal use of estrogen alone lowers breast cancer cases, deaths
MDedge ObGyn
Many older adults ‘overscreened’ for cancer
MDedge ObGyn
System provides ‘faster, less invasive’ method for breast cancer detection
MDedge ObGyn
Mammography starting at 40 cuts risk of breast cancer death
MDedge ObGyn
How effective is screening mammography for preventing breast cancer mortality?
MDedge ObGyn
Beyond baseline, DBT no better than mammography for dense breasts
MDedge ObGyn
Tailored messaging needed to get cancer screening back on track
MDedge ObGyn
One-off blast of RT, rather than weeks, for early breast cancer
MDedge ObGyn
First guideline on NGS testing in cancer, from ESMO
MDedge ObGyn
Hair dye and cancer study ‘offers some reassurance’
MDedge ObGyn